1. Saido, T. C. (2004). Towards presymptomatic diagnosis, prevention and treatment of Alzheimer’s disease. Rinsho Shinkeigaku, 11, 824–826.
2. Sastre, M., Walter, J., & Gentleman, S. M. (2008). Interactions between APP secretases and inflammatory mediators. Journal of Neuroinflammation, 5, 25.
3. Li, L. X., Dai, J. P., Ru, L. Q., et al. (2004). Effects of tanshinone on neuropathological changes induced by amyloid beta-peptide(1–40) injection in rat hippocampus. Acta Pharmacologica Sinica, 25, 861–868.
4. Mufson, E. J., Counts, S. E., Perez, S. E., et al. (2008). Cholinergic system during the progression of Alzheimer’s disease: Therapeutic implications. Expert Review of Neurotherapeutics, 8, l703–1718.
5. Zhenghua, M. Z., & Jianyin, T. J. (2008). The role of α7 nicotinic acetylcholine receptors in Alzheimer’s disease. Journal of Singxia Medical College, 30, 253–256.